ATLANTA, GA / ACCESSWIRE / December 5, 2022 / Holzer & Holzer, LLC is investigating whether SQZ Biotechnologies Company ("SQZ Bio" or the "Company") (NYSE:SQZ) complied with federal securities laws. On December 1, 2022, SQZ Biotechnologies announced that its Chief Executive Officer, Armon Sharei, was stepping down, effective immediately. The Company further announced that its "Board of Directors approved a restructuring plan which includes a workforce reduction of approximately 60 percent." Following this announcement, the Company's stock price dropped.
If you purchased SQZ Biotechnologies stock and suffered a loss on that investment, you are encouraged to contact Corey Holzer, Esq. at [email protected] or Joshua Karr, Esq. at [email protected], call our toll-free number at (888) 508-6832, or visit our website at https://holzerlaw.com/case/sqz-biotechnologies/ to discuss your legal rights.
Holzer & Holzer, LLC, an ISS top rated securities litigation law firm for 2021, dedicates its practice to vigorous representation of shareholders and investors in litigation nationwide, including shareholder class action and derivative litigation. Since its founding in 2000, Holzer & Holzer attorneys have played critical roles in recovering hundreds of millions of dollars for shareholders victimized by fraud and other corporate misconduct.More information about the firm is available through its website, www.holzerlaw.com, and upon request from the firm. Holzer & Holzer, LLC has paid for the dissemination of this promotional communication, and Corey Holzer is the attorney responsible for its content.
CONTACT:
Corey Holzer, Esq.
(888) 508-6832 (toll-free)
[email protected]
SOURCE: Holzer & Holzer